AAPL 165.4 -1.34 (-0.80%)MSFT 106.08 -1.4 (-1.30%)FB 144.04 -1.32 (-0.91%)ZNGA 3.71 +0.04 (+1.23%)NVDA 146.45 -1.46 (-0.99%)WBA 78.69 -0.4 (-0.51%)GOOG 1041.79 -8.01 (-0.76%)PIH 5 -0.12 (-2.34%)
AAPL 165.4 -1.34 (-0.80%)MSFT 106.08 -1.4 (-1.30%)FB 144.04 -1.32 (-0.91%)ZNGA 3.71 +0.04 (+1.23%)NVDA 146.45 -1.46 (-0.99%)WBA 78.69 -0.4 (-0.51%)GOOG 1041.79 -8.01 (-0.76%)PIH 5 -0.12 (-2.34%)

Cash Flow ACHN Quote Achillion P

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
NetIncome 0 0 0
Depreciation 1 1 1
DeferredIncomeT 0 0 0
StockBasedCompe 10 11 11
AccountsReceiva 0 0 0
InventoryCS 0 0 0
AccountsPayable -2 3 -2
OtherWorkingCap 0 -15 15
OtherNonCashIte -2 -1 -1
NetCashProvided 6 -66 -59
InvestmentsInPP -1 -3 -1
AcquisitionsNet 0 0 0
PurchasesOfInve -693 -499 -345
SalesMaturities 395 562 372
PurchasesOfInta 0 0 0
OtherInvestingA 0 0 0
NetCashUsedForI -299 61 26
DebtIssued 0 0 0
DebtRepayment 0 0 0
CommonStockIssu 297 0 0
CommonStockRepu 0 0 0
DividendPaid 0 0 0
OtherFinancingA 4 0 0
NetCashProvided 301 1 0
NetChangeInCash 8 -4 -34
CashAtBeginning 74 82 77
CashAtEndOfPeri 82 77 43
Achillion Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Achillion Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.